Preview Mode Links will not work in preview mode

ACC CardiaCast

Jun 17, 2022

In this episode, Drs. Matt Martinez and Ahmad Masri discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and mechanisms of action.


Jun 6, 2022

In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Dr. Tammy Brady discusses the numerous, often ignored, factors that can lead to inaccurate blood pressure assessment and the degree to which this may affect clinical management. Topics will include cuff...


Jun 3, 2022

In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Drs. Beth Abramson, Cesar Andres, Nadia Khan, and Karen Tran provide an international perspective on guidelines, care gaps, and ways to close these care gaps.


May 27, 2022

In this episode, Drs. Matt Martinez and Sara Saberi discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and what sorts of patients are best suited for this treatment.


May 13, 2022

In this episode, Dr. Michael Shapiro and Dr. Salim Virani discuss the current treatment options for FH, including statin therapy, lifestyle modifications, and non-statin therapy.